birmingham.ac.uk1h
Common antibiotic could treat inflammatory bowel disease, new study finds
Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...
Healio4h
‘Lack of patient activation’ in pediatric IBD may be poor health literacy in disguise
Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...
I was going to the toilet 40 times a day, it nearly finished my career – FA Cup star opens up on horror bowel disease
JACK FITZWATER has revealed how he thought his football career was in jeopardy when he was forced to visit the toilet 40 times a day. The defender hopes to help League One club Exeter topple ...
Medscape9h
Model May Predict Which UC Patients Risk Rehospitalization
A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...
A How-To Guide for Participating in Clinical Trials
Clinical trials help researchers studying chronic conditions answer important questions about the diseases and their treatment options. However, uncertainty about what to expect and a lack of ...
Pharmabiz13h
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...
MedPage Today19h
JAK Inhibitors Remain a Viable Option for Older Adults With IBD
SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...
themarijuanaherald23h
Study: Combination of Cannabinoids Show Promise for Treating Abdominal Pain Caused by Inflammatory Bowel Disease
A new study published in The Journal of Pharmacology and Experimental Therapeutics suggests that nonpsychotropic cannabinoids (npCBs) such as cannabidiol (CBD) and cannabigerol (CBG) may help reduce ...